Charité - Universitätsmedizin Berlin

Medical research

Study on the origins of Omicron retracted

Universitätsmedizin Berlin reported new findings on the origins of the SARS-CoV-2 variant Omicron. The team led by Prof. Jan Felix Drexler has now retracted the article, which was published in the journal Science.

Diseases, Conditions, Syndromes

Cystic fibrosis: Causal treatment suitable from childhood

Cystic fibrosis remains an incurable genetic disorder that impairs lung function and significantly reduces life expectancy. A new combination drug therapy that addresses the disorder's underlying defects offers a promising ...

Medications

COVID-19 therapies are better in combination than alone

There is a steadily growing arsenal of drugs for COVID-19. Researchers from Charité-Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU) Berlin have studied the mechanisms ...

Diseases, Conditions, Syndromes

SARS-CoV-2 disrupts timing of immune response

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response. In severe COVID-19, however, this messenger is released at the very beginning of the infection, ...

page 5 from 16